Viewing Study NCT04424056


Ignite Creation Date: 2025-12-24 @ 11:21 PM
Ignite Modification Date: 2025-12-29 @ 12:21 AM
Study NCT ID: NCT04424056
Status: UNKNOWN
Last Update Posted: 2020-06-23
First Post: 2020-06-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease
Sponsor: Assistance Publique Hopitaux De Marseille
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module